There is no direct evidence to suggest that BPC-157 causes cancer or accelerates tumor growth in humans or animals. However, due to its pro-angiogenic effects, there is a theoretical concern that it could potentially feed pre-existing occult tumors [1]. This risk is purely hypothetical and has not been quantified or substantiated by clinical data [2].
What the AI assistants say
The AI assistants collectively agree that there is no direct proof that BPC-157 causes cancer in humans. They note that BPC-157 can promote angiogenesis in preclinical models, and since tumors often exploit angiogenesis to grow and spread, there is a reasonable theoretical concern about its long-term use or use in people with active/suspected cancer [3]. The assistants also mention that BPC-157’s angiogenic effects are primarily observed in the context of tissue injury and repair, and that it promotes reparative angiogenesis, which is a physiological response aimed at restoring blood supply to damaged tissues to facilitate healing [4].
What the research actually shows
Research on BPC-157 has shown that it can stimulate the formation of new blood vessels, which is a characteristic feature of angiogenic agents [1]. However, not all angiogenic factors necessarily promote cancer. Some angiogenic factors might even have anti-cancer effects by improving blood supply to tumors and enhancing the delivery of chemotherapeutic agents [5]. In the context of BPC-157, it is important to consider the specific mechanisms by which it exerts its effects. Studies have highlighted the potential therapeutic benefits of BPC-157 in various conditions without suggesting an increased risk of cancer [3]. BPC-157 has been shown to have a strong promoting involvement in the healing process [7], and it has been suggested as a valuable candidate for further assessment in the context of bone-homeostasis [7]. Additionally, BPC-157 has been investigated for its effects on cardiac electrophysiology and blood pressure, with no indication of increased cancer risk [6]. These findings suggest that BPC-157 may have therapeutic benefits without promoting cancer growth [2].
The potential of BPC-157 to increase cancer risk needs to be evaluated in the context of its other effects, such as its anti-inflammatory properties. It has been shown that BPC-157 can reduce inflammation in various models, including adjuvant arthritis and inflammatory bowel disease [3], which are conditions often associated with an increased risk of cancer. By reducing inflammation, BPC-157 might actually lower the risk of cancer development rather than increasing it [4].
Where AI consensus and research diverge
The AI assistants and the research corpus both agree that BPC-157 has angiogenic effects and that there is no direct evidence to suggest it increases cancer risk. However, the AI assistants emphasize the theoretical concern due to BPC-157’s angiogenic effects, while the research corpus provides more context on BPC-157’s therapeutic benefits and anti-inflammatory properties, suggesting that these effects might actually lower the risk of cancer development rather than increasing it [3].
Bottom line: Based on the current literature, BPC-157 does have angiogenic effects, but there is no conclusive evidence to suggest that it increases cancer risk. Further research is needed to fully understand the relationship between BPC-157 and cancer development [1].
References
- Cancer_ Principles & Practice of Oncology
- Handbook of Biologically Active Peptides
- Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157. Vascular recruitment and gastrointestinal tract
- Pentadecapeptide BPC 157 reduces bleeding time and — Mirjana Stupnisek
- The effect of pentadecapeptide BPC 157, H-blockers — Predrag Sikiric
- The pharmacological properties of the novel peptide BPC 157 — P Sikiric（Affiliation Department of Pharmacology, Medical
- Traumatic brain injury in mice and pentadecapeptide BPC 157 — Mario Tudor
Continue your research
Part of our BPC-157: Safety, Side Effects & Regulation guide.
- What are the known side effects of BPC-157 in humans?
- Why hasn't BPC-157 been approved by the FDA, and why did the FDA restrict compounding it?
- Is BPC-157 banned by WADA for athletes, and why?
- Are there any known drug interactions with BPC-157?
Related topics:
- What role does the nitric oxide system play in BPC-157's effects?
- Does BPC-157 have antidepressant or anti-anxiety effects?
- What is BPC-157 and what are its claimed health benefits?